ARCHIVES

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

Drug Approved in Europe For Pediatric Cancer Patients

April 24, 2009

Reports On AACR Scientific Sessions

May 21, 1976

Search Committee Finishes Job, Submits Choices To Califano

April 15, 1977

Karkin, Hatfield Vow to Amend Health Reform To Include Trust Fund For Medical Research

June 4, 1993

ASCO Urges Increase In NIH, NCI Budgets.

January 25, 2008

Research Training – On The Road Back, With Trainee Stipends, Payback Feature

June 14, 1974